JP2007513992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007513992A5 JP2007513992A5 JP2006544346A JP2006544346A JP2007513992A5 JP 2007513992 A5 JP2007513992 A5 JP 2007513992A5 JP 2006544346 A JP2006544346 A JP 2006544346A JP 2006544346 A JP2006544346 A JP 2006544346A JP 2007513992 A5 JP2007513992 A5 JP 2007513992A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic composition
- adjuvant
- composition according
- immunogen
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0329146.5A GB0329146D0 (en) | 2003-12-16 | 2003-12-16 | Vaccine |
| PCT/EP2004/014379 WO2005058349A2 (en) | 2003-12-16 | 2004-12-14 | Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007513992A JP2007513992A (ja) | 2007-05-31 |
| JP2007513992A5 true JP2007513992A5 (cg-RX-API-DMAC7.html) | 2007-12-20 |
Family
ID=30471161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006544346A Pending JP2007513992A (ja) | 2003-12-16 | 2004-12-14 | 自己免疫疾患の治療用のｉｌ−１２又はｉｌ−２３を含むワクチン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070048261A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1694358A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007513992A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2548512A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0329146D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005058349A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005108425A1 (en) * | 2004-05-10 | 2005-11-17 | Cytos Biotechnology Ag | Il-23 p19 antigen array and uses thereof |
| ES2544877T3 (es) | 2005-10-12 | 2015-09-04 | Idera Pharmaceuticals | Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll |
| US8377898B2 (en) * | 2006-10-12 | 2013-02-19 | Idera Pharmaceuticals, Inc. | Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| TWI426918B (zh) | 2007-02-12 | 2014-02-21 | Merck Sharp & Dohme | Ｉｌ-２３拮抗劑於治療感染之用途 |
| EP3087988A3 (en) | 2008-10-06 | 2017-03-01 | Idera Pharmaceuticals, Inc. | Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto |
| EP2480251B1 (en) | 2009-09-21 | 2025-12-03 | Peptinov | Carrier conjugates of il-23-peptides and their induced antibodies |
| CN107012149A (zh) | 2010-11-19 | 2017-08-04 | 艾德拉药物股份有限公司 | 调控基于toll‑样受体的免疫应答的免疫调节寡核苷酸(iro)化合物 |
| AU2014235120B2 (en) * | 2013-03-15 | 2017-01-05 | The Trustees Of The University Of Pennsylvania | Vaccines having an antigen and interleukin-23 as an adjuvant |
| CN105705522B (zh) * | 2013-05-14 | 2020-09-15 | 上海亨臻实业有限公司 | 针对低免疫原性蛋白的表位疫苗及其制法和用途 |
| WO2015157561A1 (en) * | 2014-04-09 | 2015-10-15 | La Jolla Institute For Allergy And Immunology | Specific and unique t cell responses and molecular signatures for treatment and diagnosis of mycobacterium tuberculosis |
| CA2986494A1 (en) * | 2015-06-03 | 2016-12-08 | Affiris Ag | Il-23-p19 vaccines |
| GB201522329D0 (en) * | 2015-12-17 | 2016-02-03 | Glaxosmithkline Biolog S A And Inst Nat De La Sante Et De La Rech Medicale Inserm And Université Pie | Use of adjuvants for the prevention and/or treatment of autoimmune diseases |
| PL3458083T3 (pl) | 2016-05-18 | 2023-03-13 | Modernatx, Inc. | Polinukleotydy kodujące interleukinę-12 (il12) i ich zastosowania |
| AU2018270111B2 (en) | 2017-05-18 | 2022-07-14 | Modernatx, Inc. | Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof |
| WO2019051127A1 (en) | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| GB201907413D0 (en) * | 2019-05-24 | 2019-07-10 | Univ Helsinki | Viral vector |
| AU2021311894B2 (en) | 2020-07-22 | 2025-02-27 | 3H Bio. Co., Ltd. | Peptide for immunotherapeutic agent |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA95960B (en) * | 1994-03-14 | 1995-10-10 | Genetics Inst | Use of interleukin-12 antagonists in the treatment of autoimmune diseases |
| WO1996040755A1 (en) * | 1995-06-07 | 1996-12-19 | Dlo Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | An improved peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone lhrh, and analogs of the lhrh tandem repeat peptide and their use as vaccine |
| AU1407997A (en) * | 1995-12-01 | 1997-06-19 | Beth Israel Hospital | Il-12 p40 subunit fusion polypeptides and uses thereof |
| GB9712347D0 (en) * | 1997-06-14 | 1997-08-13 | Smithkline Beecham Biolog | Vaccine |
| KR100764256B1 (ko) * | 1998-01-23 | 2007-10-05 | 에프. 호프만-라 로슈 아게 | 인간 인터루킨-12에 대한 항체 |
| ATE480566T1 (de) * | 1998-06-15 | 2010-09-15 | Quest Pharmatech Inc | Immuntherapeutische zusammensetzung und verfahren zur behandlung von prostatakrebs |
| US6902734B2 (en) * | 2000-08-07 | 2005-06-07 | Centocor, Inc. | Anti-IL-12 antibodies and compositions thereof |
| US20030082179A1 (en) * | 2001-07-03 | 2003-05-01 | Hutchison James Scott | Parathyroid hormone antibodies and related methods |
-
2003
- 2003-12-16 GB GBGB0329146.5A patent/GB0329146D0/en not_active Ceased
-
2004
- 2004-12-14 CA CA002548512A patent/CA2548512A1/en not_active Abandoned
- 2004-12-14 WO PCT/EP2004/014379 patent/WO2005058349A2/en not_active Ceased
- 2004-12-14 EP EP04803988A patent/EP1694358A2/en not_active Withdrawn
- 2004-12-14 US US10/582,810 patent/US20070048261A1/en not_active Abandoned
- 2004-12-14 JP JP2006544346A patent/JP2007513992A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| Guan et al. | Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses | |
| JP2022133396A5 (cg-RX-API-DMAC7.html) | ||
| CN1372473A (zh) | 包含皂甙和免疫刺激寡核苷酸的佐剂组合物 | |
| JP2011042693A5 (cg-RX-API-DMAC7.html) | ||
| WO2003090686A3 (en) | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality | |
| WO2002096350A3 (en) | Immunogenic peptide composition for the prevention and treatment of alzheimer's disease | |
| DK0680338T3 (da) | Gangliosid-KLH-konjugat-vacciner med QS-21 | |
| JP2006506441A5 (cg-RX-API-DMAC7.html) | ||
| EP1329226A3 (en) | Hapten-Carrier Conjugates for use in Drug Abuse Therapy | |
| JP2003518507A5 (cg-RX-API-DMAC7.html) | ||
| JP2002531521A5 (cg-RX-API-DMAC7.html) | ||
| JP2003513935A5 (cg-RX-API-DMAC7.html) | ||
| JP2007513992A (ja) | 自己免疫疾患の治療用のｉｌ−１２又はｉｌ−２３を含むワクチン | |
| WO2003020765A3 (en) | Vaccine therapies and prophylactic treatments of atherosclerotic diseases | |
| WO1996030049A3 (en) | Hapten-carrier conjugates for use in drug-abuse therapy | |
| ES2701084T3 (es) | Compuestos inmunogénicos que comprenden péptido gp41 de VIH acoplado a proteína portadora CRM197 | |
| US20080038291A1 (en) | Method to reduce the physiologic effects of drugs on mammals | |
| TWI615148B (zh) | 疫苗 | |
| JP2002538219A5 (cg-RX-API-DMAC7.html) | ||
| Richards et al. | Liposome‐stabilized oil‐in‐water emulsions as adjuvants: Increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen | |
| WO2004080375A3 (en) | Vaccine therapy of atherosclerosis | |
| WO2004081045A3 (en) | Vaccine related to modified apolipoprotein c-iii | |
| JP2016532712A (ja) | 薬物中毒に対するワクチン組成物 | |
| RU98112608A (ru) | Иммуногенная композиция [на основе] tlp |